Skip to contentB
Biolargo, Inc.
B
BLGOBiolargo, Inc. Q2 2016 · 10-Q
Revenue$38.99K$38.99K−2.2% vs Q2 2015 Net Income-$1.67M-$1.67MN/M vs Q2 2015 EPS Diluted-$0.02-$0.02N/M vs Q2 2015 Gross Profit$23,229+193.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
Operating Cash Flowderived-$707,155N/M Margins · derivedGross margin59.6%+39.7 pt vs Q2 2015
Operating margin-3163.1%−599.8 pt vs Q2 2015
Net margin-4279.3%+290.8 pt vs Q2 2015
ended Jun 30, 2016 · filed Aug 15, 2016 · 46 d after period end